Ontology highlight
ABSTRACT: Purpose
Relaxin (RLX) is a transforming growth factor-β1 (TGF-β1) antagonist that is believed to function as a potent collagen re-arranger and a major suppressor of extracellular matrix components. Adenoviruses (Ads) are accepted vectors for cancer gene therapy. However, repeated treatments of Ad are limited by short-term biological activity in vivo. The efficacy of sustained RLX expression to scar remodeling was assessed using an injectable alginate gel-matrix system.Materials and methods
Pig scar tissue was treated with relaxin-expressing Ad loaded in alginate gel (gel/Ad-RLX). Surface areas, color, and pliability of scars were compared, and various factors influencing scar formation and collagen arrangement were analyzed.Results
Gel/Ad-RLX decreased scar size, co
SUBMITTER: Yun IS
PROVIDER: S-EPMC6704020 | biostudies-literature | 2019 Sep
REPOSITORIES: biostudies-literature